Format

Send to

Choose Destination
Support Care Cancer. 2017 May;25(5):1741. doi: 10.1007/s00520-017-3608-9.

Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types.

Author information

1
Department of Oncology, Asan Medical Center, University of Ulsan, College of Medicine, 88 Olympic ro 43 gil, Sonpa-gu, Seoul, South Korea.
2
Department of Internal Medicine, Chung-Ang University College of Medicine, 101 Heukseok-ro, Dongjak-gu, Seoul, South Korea. alsaba@hanmail.net.
3
Department of Obstetrics and Gynecology, Seoul National University College of Medicine, 101 Daehak-ro Jongno-gu, Seoul, South Korea.
4
Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Korea University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul, South Korea.
5
Department of Obstetrics and Gynecology, School of Medicine, Keimyung University, 56 Dalseungro Jungku, Daegu, South Korea.
6
Department of Medical Oncology, Seoul St. Mary's Hospital, The Catholic University of Korea, 90 1 Hyehwa-dong, Jongno-gu, Seoul, South Korea.
7
Division of Allergy and Respiratory Medicine, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, 170 Jomaru-ro, Wonmi-gu, Bucheon, South Korea.
8
Division of Hematology-Oncology, Department of Medicine, The Samsung Medical Center, Sungkyunkwan University School of Medicine, 135-710 Irwon-dong, Gangnam-gu, Seoul, South Korea.
9
Department of Surgery, Kyung Hee University School of Medicine, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, South Korea.
10
Division of Hematology and Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon Regional Cancer Center, Gachon University School of Medicine, 1198 Guwol-dong, Namdong-Gu, Incheon, South Korea.
11
Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, South Korea.
12
Merck Sharp & Dohme, Seoul City Credit Building, 163, Mapo-daero, Mapo-gu, Seou, South Korea.
PMID:
28197847
DOI:
10.1007/s00520-017-3608-9

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center